期刊文献+

两性霉素B聚乳酸普鲁兰纳米胶束的制备及评价

Preparation and in vitro characterization of amphotericin B poly(dl-lactide)-pullulan micelles
下载PDF
导出
摘要 目的制备两性霉素B聚乳酸普鲁兰(PLA-pullulan)纳米胶束,并进行体外评价。方法以新型两亲性高分子PLA-pullulan为载体材料,采用薄膜水化法制备两性霉素B纳米胶束,并分别采用透射电镜、激光粒径仪和zeta电位分析仪对胶束的形态、粒径和表面电位进行表征,测定其包封率、载药量和体外释放动力学,考察其药物分散状态和溶血毒性。结果所制备的两性霉素B聚乳酸普鲁兰纳米胶束溶液外观透明,电镜下呈圆整的球形,平均粒径为152.1 nm,包封率为71.1%,载药量达10.9%,24 h的累积释放量为10.01%,溶血毒性低于两性霉素B去氧胆酸钠胶束。结论聚乳酸普鲁兰胶束是两性霉素B潜在的优良纳米载体,具有良好的应用价值。 Objective To prepare and characterize the amphotericin B(Am B) loaded poly(dl-lactide) pullulan(PLA-pullulan) nanomicelles in vitro. Methods PLA-pullulan, a new amphiphilic polymer, was used for loading Am B with thin film dispersion method. The morphology, diameter and surface potential of the micelles were characterized by transmission electron microscopy, size and zeta potential analyzer. The drug loading content, entrapment efficiency and in vitro release of Am B loaded micelles were determined. The relative aggregation state of the encapsulated Am B and hemolytic toxicity were studied. Results The micelle was clear and transparent, globular shaped. The average particle size, drug loading content and entrapment efficiency were 152.1 nm with narrow distribution, 71.1% and 10.9%, respectively. The cumulative release amount of micelle within 24 h is 10.01%. Am B loaded micelles showed lower hemolysis than Am B solutions. Conclusions PLA-pullulan micelles, used as nanocarrier of amphotericin B, has a very good application prospect.
出处 《中国药剂学杂志(网络版)》 2016年第2期33-42,共10页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 胶束 薄膜水化法 两性霉素B 聚乳酸普鲁兰 体外评价 pharmaceutics micelles thin film dispersion method amphotericin B poly(dl-lactide)-pullulan in vitro characterization
  • 相关文献

参考文献18

  • 1Tollemar J,Andersson S,Ringdén O,Tydén G.A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients. Mycoses . 1992
  • 2Legrand P,Romero E A,Cohen B E,Bolard J.Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. Antimicrobial Agents and Chemotherapy . 1992
  • 3Yan Wang,Yuanyuan Liu,Yang Liu,Wen Zhou,Hemei Wang,Guoyun Wan,Duxin Sun,Ning Zhang,Yinsong Wang.??A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma(J)International Journal of Pharmaceutics . 2015 (1-2)
  • 4Xiao-Jiao Tang,Jun Huang,Liang-Yu Xu,Yang Li,Juan Song,Yue Ma,Li Yang,Dan Yuan,Hai-Yang Wu.??Microwave-assisted rapid synthesis, characterization and application of poly ( d,l -lactide)-graft-pullulan(J)Carbohydrate Polymers . 2014
  • 5Barwicz J,Christian S,Gruda I.Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrobial Agents and Chemotherapy . 1992
  • 6Sabra R,Branch R A.Amphotericin B nephrotoxicity. Drug safety : an international journal of medical toxicology and drug experience . 1990
  • 7Seyyed Ali Mozaffarpur,Mohsen Naseri,Mohammad Reza Esmaeilidooki,Mohammad Kamalinejad,Ali Bijani.The effect of cassia fistula emulsion on pediatricfunctional constipation in comparison with mineraloil: a randomized, clinical trial. DARU Journal of Pharmaceutical Sciences . 2012
  • 8Stephan Harbarth,Stanley L Pestotnik,James F Lloyd,John P Burke,Matthew H Samore.??The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy(J)The American Journal of Medicine . 2001 (7)
  • 9Máté Virágh,Dóra V?r?s,Zoltán Kele,Laura Kovács,ádám Fizil,Gergely Lakatos,Gergely Maróti,Gyula Batta,Csaba Vágv?lgyi,László Galgóczy.??Production of a defensin-like antifungal protein NFAP from Neosartorya fischeri in Pichia pastoris and its antifungal activity against filamentous fungal isolates from human infections(J)Protein Expression and Purification . 2014
  • 10Afsaneh Lavasanifar,John Samuel,Glen S Kwon.??Micelles self-assembled from poly(ethylene oxide)- block -poly( N -hexyl stearate l -aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B(J)Journal of Controlled Release . 2001 (1)

二级参考文献28

  • 1冯敏,潘仕荣,吴伟荣.两性霉素B/聚乙二醇-聚谷氨酸苄酯纳米球溶血毒性的研究[J].中国药科大学学报,2004,35(3):263-266. 被引量:6
  • 2邵英,路来金,荣莉,彭维海,蓝珊珊,张舵.聚L-乳酸/聚L-乳酸接枝的羟基磷灰石复合材料的生物相容性[J].吉林大学学报(医学版),2007,33(1):57-60. 被引量:14
  • 3吴瑞珍,谭瑞珠,梁超莲.两性霉素B常见不良反应的临床观察与护理[J].护理研究(下旬版),2007,21(1):246-247. 被引量:6
  • 4GIBBS W J, DREW R H, PERFECT J R. Liposomal amphoterlcin B: clinical experience and perspectives[ J]. Eepert Rev Anti Infect Ther, 2005, 3(2): 167-181.
  • 5TANGGZ WANGHY SHIXX.Introduction foreign AraB lipoid preparations.上海医药,2005,26(6):274-276.
  • 6BARRETT J P, VARDULAKI K A, CONLON C, et al. A systematic review of the antifungal effectiveness and tolerability of amphoterlcin B formulations [ J ] . Clin Ther, 2003, 25 ( 5 ) : 1295-1320.
  • 7GOLENSER J, DOMB A. New formulations and derivatives of amphotericin B for treatment of leishmaniasis [ J ]. Mini Rev Med Chem, 2006, 6(2) : 153-162.
  • 8SACHS-BARRABLE K, LEE S D, WASAN E K, et al. Enhancing drug absorption using lipids : A case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections[ J]. Adv Drug Deliv Rev, 2008, 60(6): 692-701.
  • 9CHOI K C, BANG J Y, KIM P I, et al. Amphotericin B-incorporated polymeric micelles composed of poly (d, 1-lactide-co-glycolide)/dextran graft copolymer[ J]. Int J Pharm, 2008, 355 ( 1-2 ) : 224-230.
  • 10VIEIRA D B, CARMONA-RIBEIRO A M. Cationic nanoparticles for delivery of amphotericin B : preparation, characterization and activity in vitro[J]. J Nanobiotechnol, 2008, 6:6.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部